D-0502-2023 Class II Terminated
FDA drug recall D-0502-2023 was initiated by RemedyRepack Inc. on Mar 20, 2023 and is designated Class II. Reason for recall: cGMP Deviations The recall status is terminated (terminated Oct 19, 2023). Affected quantity: a) 76 bottles, b)151 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Apr 12, 2023
- Initiation Date
- Mar 20, 2023
- Termination Date
- Oct 19, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- a) 76 bottles, b)151 bottles
Product description
Rosuvastatin 40mg tablets, packaged in a) 45-count bottles (NDC 70518-1311-01), and b) 90-count bottles (NDC 70518-0484-00), Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701.
Reason for recall
cGMP Deviations
Distribution pattern
RemedyRepack distributed product to consignees nationwide within the United States
Code information
Lot # a): B2038806-123022, B2014185-121422, B1925528-102522, Exp. Date 07/31/2025. Lot #: b): B2080829-012823, B1938007-110222, B2038746-123022, Exp. Date 07/31/2025.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0502-2023
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026